Risk of Major Cardiovascular Events in People with Down Syndrome

• Christopher G. Sobey ,

  Contributed equally to this work with: Christopher G. Sobey, Courtney P. Judkins

  * E-mail: chris.sobey@monash.edu

  Affiliations Cardiovacular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, Victoria, Australia, Department of Surgery, Monash Medical Centre, Southern Clinical School, Monash University, Clayton, Victoria, Australia

  ⨯
• Courtney P. Judkins ,

  Contributed equally to this work with: Christopher G. Sobey, Courtney P. Judkins

  Affiliation Cardiovacular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, Victoria, Australia

  ⨯
• Vijaya Sundararajan,

  Affiliations Stroke and Ageing Research Group, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia, Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia

  ⨯
• Thanh G. Phan,

  Affiliations Stroke and Ageing Research Group, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia, Stroke Unit, Monash Health, Melbourne, Australia

  ⨯
• Grant R. Drummond,

  Affiliations Cardiovacular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, Victoria, Australia, Department of Surgery, Monash Medical Centre, Southern Clinical School, Monash University, Clayton, Victoria, Australia

  ⨯
• Velandai K. Srikanth

  Affiliations Stroke and Ageing Research Group, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia, Stroke Unit, Monash Health, Melbourne, Australia, Menzies Research Institute, Hobart, Tasmania, Australia

  ⨯